Results 241 to 250 of about 2,770,733 (305)
Economic and productivity outcomes of workplace health programmes incorporating blood-based laboratory screening: a systematic review. [PDF]
Swadźba D, Makuch S, Agrawal S.
europepmc +1 more source
Hyperoside ameliorates metabolic dysfunction in high‐fat diet‐induced type 2 diabetic mice, accompanied by enhanced brown adipose tissue thermogenic activity, inguinal white adipose tissue browning‐related changes, reduced M1 macrophage polarization, and gut microbiota remodeling.
WeiFeng Cai +7 more
wiley +1 more source
Impact of Dyslipidemia on Clinical Outcomes Among Cancer Patients Treated With Immune Checkpoint Inhibitors. [PDF]
Liang Y +15 more
europepmc +1 more source
CA directly binds to and activates AMPK to suppress NLRP3/GSDMD signaling, thereby alleviating hepatocyte pyroptosis in T2DM mice. ABSTRACT Type 2 diabetes mellitus (T2DM) is frequently accompanied by chronic ethanol (ET) consumption, which worsens metabolic dysregulation and organ damage.
Huaiying Tang +13 more
wiley +1 more source
By shaping the protein corona, lipid composition directs LNP tropism and enables the preferential delivery of a TIMP1‐targeting siRNA to liver macrophages. In a murine model of primary biliary cholangitis, this strategy promoted macrophage reprogramming and attenuated liver fibrosis.
Naths G. Sukubo +15 more
wiley +1 more source
Screening Signals of Reference-Defined Metabolic Syndrome Using HbA1c and LDL Cholesterol: An Explainable Machine Learning Study. [PDF]
Demir O.
europepmc +1 more source
Serum versus lithium-heparin plasma for lipid testing: matrix-related bias and calculated LDL-C classification. [PDF]
Kouched N +5 more
europepmc +1 more source
Associations between early improvements in atherogenic lipids and reported dietary changes after RYGB: a pilot exploratory analysis in women with type 2 diabetes. [PDF]
Lemos GO +9 more
europepmc +1 more source

